Trial Profile
Bioavailability and effects of food on the pharmacokinetics of ENMD-2076 in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Jul 2013
Price :
$35
*
At a glance
- Drugs ENMD 2076 (Primary)
- Indications Acute myeloid leukaemia; Breast cancer; Multiple myeloma; Ovarian cancer; Soft tissue sarcoma
- Focus Pharmacokinetics
- 30 Jul 2013 New trial record
- 29 Jul 2013 This trial has been initiated, according to an EntreMed media release.